Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

Frank P. Bymaster, Wei Zhang, Petra A. Carter, +5

Psychopharmacology

Psychoactive DrugPsychiatryNeurophysiologyPrefrontal CortexMedicine +10

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor

Donald R. Gehlert, Anantha Shekhar, Stéphanie Morin, +6

European Journal of Pharmacology

Behavioral SciencesSocial Interaction TestStress HormonePsychiatryBehavioral Neuroscience +10

Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice

Daniel G. Smith, Eleni T. Tzavara, Janice Shaw, +6

Journal of Neuroscience

Preclinical Evaluation of Melanin-Concentrating Hormone Receptor 1 Antagonism for the Treatment of Obesity and Depression

Donald R. Gehlert, Kurt Rasmussen, Janice Shaw, +7

Journal of Pharmacology and Experimental Therapeutics

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt, +9

Bioorganic & Medicinal Chemistry Letters

New AntidepressantsPsychoactive DrugPsychiatryFunctional SelectivityMedicine +10

Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon

Over Cabrera, James Ficorilli, Janice Shaw, +5

Journal of Biological Chemistry

5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion

M. Joelle Dill, Janice Shaw, Jeff W. Cramer, +1

Pharmacology Biochemistry and Behavior

ObesityAppetiteNutritionEnergy HomeostasisMedicine +8

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4

Vincent P. Rocco, Patrick Spinazze, Todd J. Kohn, +8

Bioorganic & Medicinal Chemistry Letters

New AntidepressantsPsychoactive DrugPsychiatryFunctional SelectivityMedicine +10

Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2

Kumiko Takeuchi, Todd J. Kohn, Nicholas A Honigschmidt, +11

Bioorganic & Medicinal Chemistry Letters

Molecular PharmacologyPsychoactive DrugPsychiatryFunctional SelectivityMedicine +10

Monoaminergic compensation in the neuropeptide Y deficient mouse brain

Donald R. Gehlert, Linda Thompson, Susan K. Hemrick-Luecke, +1

Neuropeptides

Neuropeptide ReceptorMonoaminergic CompensationNeurologyNeuroscienceCentral Nervous System +3